Accent Therapeutics

Ver el organigrama con sus 11 ejecutivos principales

Biografías más buscadas en Accent Therapeutics

• Shakti Narayan, Director and Chief Executive Officer
• David Brower, Chief Business Officer
• Robert Copeland, Chief Scientific Officer and President

Recientes movimientos de ejecutivos en Accent Therapeutics

• Jason Sager, se ha incorporado a la empresa como Chief Medical Officer  (noticia publicada el 22 de septiembre de 2023).
• Steven Mennen, se ha incorporado a la empresa como Vice President of Pre-Clinical Development  (noticia publicada el 22 de septiembre de 2023).

Crear su alerta
para seguir los movimientos de los ejecutivos en Accent Therapeutics.

Accent Therapeutics tiene 2.277 competidores entre los que se incluyen Eurofins (Luxemburgo), Lonza (Suiza) y Adaptive Phage Therapeutics (Estados Unidos).

Popular M&A news in Biotecnología

• Histogen has filed for bankruptcy protection  (publicado el 19 de abril de 2024).
• Bruker has announced the acquisition of NanoString Technologies  (publicado el 18 de abril de 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (publicado el 16 de abril de 2024).

Otros contactos sugeridos en el sector Biotecnología

• Ali Behbahani - Non-Executive Director en Adaptimmune Therapeutics
• Vik Bajaj - Director en Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board en Sensorion

Saber más sobre el sector Biotecnología >

Últimos comunicados de prensa de Accent Therapeutics

• Accent Therapeutics Appoints Oncology Drug Development Veteran Julie Hambleton to its Board of Directors - Accent Therapeutics
• Fierce Biotech names Accent Therapeutics as one of its “Fierce 15” Biotech Companies of 2020 - Accent Therapeutics
• Accent Therapeutics and AstraZeneca to Discover and Develop Novel Cancer Therapeutics in New Collaboration - Accent Therapeutics
• Ipsen adds another program into its pre-clinical R&D Oncology pipeline through an exclusive worldwide collaboration with Accent Therapeutics, targeting the RNA modifying protein, METTL3 - Accent Therapeutics
• Fierce Biotech names Accent Therapeutics as one of its “Fierce 15” Biotech Companies of 2020
• Accent Therapeutics and AstraZeneca to Discover and Develop Novel Cancer Therapeutics in New Collaboration
• Accent Therapeutics Appoints Oncology Drug Development Veteran Julie Hambleton to its Board of Directors
• View more press releases Close

Redes sociales sobre Accent Therapeutics

• Accent Therapeutics en Wikipedia, Google News y Yahoo Finance
• Accent Therapeutics en LinkedIn, Twitter y YouTube

Contactar a través de e-mail con sus ejecutivos Shakti Narayan

Llame a Accent Therapeutics al +1 339...

Ver el organigrama

Register to receive your alert

Señalar un error